‘Game Changer’ AI Detects Hidden Heart Attack Risk

Recent advancements in artificial intelligence (AI) have introduced a groundbreaking technology capable of identifying individuals at risk of a heart attack over the next decade. This revolutionary AI model has been described as “game changing” by scientists due to its ability to detect underlying heart inflammation that conventional CT scans cannot reveal. Here’s an in-depth look at this transformative technology and its potential impact on cardiovascular health.

Unveiling the AI Technology

The AI technology, developed by Caristo Diagnostics—a spinout company from Oxford University—focuses on detecting coronary inflammation and plaque that are not visible through standard CT scans. These scans combine X-ray imaging with computer technology to provide detailed images of the heart and blood vessels. However, they often miss subtle signs of inflammation that can precede serious cardiovascular issues.

The AI model, known as CaRi-Heart, analyzes routine CT scans of patients who present with chest pain. By using advanced algorithms, it identifies signs of coronary inflammation and plaque buildup. This method represents a significant leap forward in detecting the biological processes leading to heart disease, which were previously invisible to traditional imaging techniques.

Pilot Projects and Future Prospects

Currently, a pilot project supported by NHS England is underway at five hospital trusts across the UK, including Oxford, Milton Keynes, Leicester, Liverpool, and Wolverhampton. This initiative aims to evaluate the effectiveness of the AI technology in real-world settings. A decision on whether this technology will be adopted more widely within the NHS is expected within the coming months.

Caristo Diagnostics is also working on adapting this technology to prevent other conditions such as strokes and diabetes, broadening its potential impact on public health.

The Science behind the Technology

Prof Keith Channon from the University of Oxford highlights the significance of this technology. He notes that for the first time, it allows for the detection of biological processes that lead to narrowings and blockages within the heart before they become critical. The AI system analyzes CT scan images to detect early signs of inflammation, which is a key indicator of cardiovascular risk.

Addressing the Cardiovascular Disease Crisis

Cardiovascular disease remains a significant health issue in the UK, with approximately 7.6 million people living with heart disease. The annual cost to the NHS in England is estimated at £7.4 billion. Each year, around 350,000 patients are referred for cardiac CT scans, according to the British Heart Foundation (BHF).

The Orfan study (Oxford Risk Factors and Non-invasive Imaging), involving 40,000 patients, revealed that a large proportion of patients who received CT scans were sent back to primary care without a defined prevention or treatment plan. The study found that individuals with detected coronary inflammation had a 20 to 30 times higher risk of dying from a cardiac event within the next decade. Utilizing AI technology, 45% of these high-risk patients were subsequently prescribed medication or advised on lifestyle changes to mitigate future heart attacks.

Personal Impact: A Patient’s Experience

Ian Pickford, a 58-year-old from Barwell, Leicestershire, experienced a profound shift in his health management after being referred for a CT scan in November 2023. Enrolled in the Orfan study at the University Hospitals of Leicester NHS Trust, Pickford was diagnosed with a high risk of heart attack based on the AI analysis of his scan. He was prescribed statins, advised to quit smoking, and encouraged to increase his physical activity.

“It’s a huge wake-up call,” said Pickford. “Seeing the results on paper made me realize how serious my condition was. It’s a daily reminder to take action and make necessary changes.”

Advancing Heart Disease Prevention

Prof Charalambos Antoniades, the lead researcher of the Orfan study, emphasizes that traditional risk calculators only assess general factors like diabetes, smoking, or obesity. The new AI technology, however, provides a more precise assessment by identifying active disease processes in the arteries before clinical symptoms develop. This early detection enables more proactive treatment strategies to prevent heart disease progression and subsequent heart attacks.

Regulatory and Global Review

The National Institute for Health and Care Excellence (NICE) is currently reviewing the AI technology to determine its suitability for broader NHS adoption. Meanwhile, the technology is also under review in the US and has already received approval for use in Europe and Australia. The positive reception and ongoing evaluations underscore the potential of this AI system to transform cardiovascular disease management globally.

Conclusion: A New Era in Heart Disease Detection

The introduction of AI technology to detect hidden heart attack risks marks a significant advancement in cardiovascular health. By identifying inflammation that conventional scans miss, this technology has the potential to revolutionize how we prevent and manage heart disease. As pilot projects progress and regulatory reviews continue, the hope is that this innovative tool will soon become an integral part of cardiovascular care, offering patients a new level of early detection and prevention.